ASTANA – Yerzhan Yelekeyev, Chairman of the Management Board of JSC National Company Kazakh Invest, and Sultangali Kinzhakulov, Deputy Chairman of the Investment Committee of the Ministry of Foreign Affairs of Kazakhstan, met with the leadership of the Chinese company Zhejiang Sunny Group Co., Ltd. The meeting was to discuss the potential construction of a plant in Kazakhstan for producing cornstarch and thiamulin, with plans for future expansion into biologically based products.
Jianhui Chen, the Chairman of Zhejiang Sunny Group Co., Ltd., highlighted the favorable conditions in Kazakhstan for the plant’s construction. These include its strategic location, the availability of land for corn cultivation, and its proximity to local suppliers. He stated that the company is prepared to invest $150 million in the project, which would create 500 permanent jobs.
The products manufactured at the proposed plant are intended for export to European Union countries and Southeast Asia. They will be used in various industries, including food, pharmaceuticals, chemicals, and veterinary medicine. The project also includes provisions for industrial waste processing, industrial wastewater treatment, and the use of installations to minimize atmospheric emissions from natural gas combustion.
Zhejiang Sunny Group Co., Ltd. is a producer of biopharmaceutical products. It is one of the few companies in the biopharmaceutical industry with capabilities in both microbial fermentation and synthesis.
